Total homocysteine is associated with nephropathy in non-insulin- dependent diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 48, Issue 9, 1999, Pages 1096-1101

  Stabler, Sally P ^a,b   Estacio, Raymond ^a   Jeffers, Barrett W ^a   Cohen, Jeffrey A ^a   Allen, Robert H ^a   Schrier, Robert W ^a  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYANOCOBALAMIN; CYSTATHIONINE; FOLIC ACID; HOMOCYSTEINE; METHYLMALONIC ACID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CREATININE CLEARANCE; CYANOCOBALAMIN DEFICIENCY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEINURIA; VITAMIN DEFICIENCY;

EID: 0032820328     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90121-X     Document Type: Article

References (43)

1. Kannel WB, McGee DL: Diabetes and glucose tolerance as risk factors for cardiovascular disease. Diabetes Care 2:120-126, 1979
2. Pyorala K: Diabetes and heart disease, in Mogensen CE (ed): Prevention and Treatment of Diabetic Late Complications. New York, NY. de Gruyter, 1989, pp 151-168
3. Ueland PM, Refsum H, Brattstrom L: Plasma homocysteine and cardiovascular disease, in Francis RBJ (ed): Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function. New York, NY, Dekker, 1992, pp 183-236
4. Arnesen E, Refsum H, Bonaa KH, et al: Serum total homocysteine and coronary heart disease Int J Epidemiol 24:704-709, 1995
5. Stampfer MJ, Mahnow MR, Willett WC, et al: A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268:877-881, 1992
6. Boushey CJ, Beresford SAA, Omenn GS, et al: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes. JAMA 274:1049-1057, 1995
7. 12, and folate. Am J Epidemiol 143:845-859, 1996
8. 6 and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 57:47-53, 1993
9. Ubbink JB, van der Merwe A, Vermaak WJH, et al: Hyperhomocysteinemia and the response to vitamin supplementation. Clin Invest 71:993-998, 1993
10. Hultberg B, Agardh E, Andersson A, et al: Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy, in type I diabetes mellitus. Scand J Clin Lab Invest 51:277-282, 1991
11. Agardh C-D, Agardh E, Anderson A. et al: Lack of association between plasma homocysteine levels and microangiopathy in type I diabetes mellitus. Scand J Clin Lab Invest 54:637-641, 1994
12. Araki A, Sako Y, Ito H: Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: Effect of parenteral methylcobalamin treatment. Atherosclerosis 103:149-157, 1993
13. Munshi MN, Stone A, Fink L, et al: Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease. Metabolism 45:133-135, 1996
14. Stabler SP, Marcell PD, Podell ER, et al: Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry J Clin Invest 81:466-474, 1988
15. Kang SS, Wong PWK, Norusis M: Homocystinemia due to folate deficiency. Metabolism 36.458-462, 1987
16. Savage DG, Lindenbaum J, Stabler SP, et al: Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 96:239-246, 1994
17. 6 status on homocysteine metabolism. J Clin Invest 98:177-184, 1996
18. Mudd SH, Levy HL, Skovby F: Disorders of transsulfuration, in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and Molecular Bases of Inherited Disease. New York, NY, McGraw-Hill, 1995, pp 1279-1328
19. Wilcken DEL, Gupta VJ: Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulfide. Eur J Clin Invest 9:301-307, 1979
20. Soria C, Chadefaux B, Coude M, et al: Concentrations of total homocysteine in plasma in chronic renal failure. Clin Chem 36:2137-2138, 1990
21. Hultberg B, Andersson A, Sterner G: Plasma homocysteine in renal failure. Clin Nephrol 40:230-234, 1993
22. Arnadottir M, Hultberg B, Nilsson-Ehle P, et al: The effect of reduced glomerular filtration rate on plasma total homocysteine concentrations. Scand J Clin Lab Invest 56:41-46, 1996
23. Andersson A, Brattstrom L, Israelsson B, et al: Plasma homocysteine before and after methionine loading with regard to age, gender and menopausal status. Eur J Clin Invest 22:79-87, 1992
24. Brattstrom L, Lindgren A, Israelsson B, et al: Homocysteine and cysteine. Determinants of plasma level in middle-aged and elderly subjects. J Intern Med 236:633-641, 1994
25. Lindenbaum J, Rosenberg IH, Wilson PWF, et al: Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 60:2-11, 1994
26. Estacio RO, Savage S, Nagel NJ, et al: Baseline characteristics of participants in the Appropriate Blood Pressure Control in Diabetes Trial. Control Clin Trials 17:242-257, 1996
27. Savage S, Nagel NJ, Estacio RO, et al: The ABCD (Appropriate Blood Pressure Control in Diabetes) Trial: Rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes. Online J Curr Clin Trials, Nov 24, 1993, Doc. no. 104
28. Early Treatment of Diabetic Retinopathy Study Research Group: Grading diabetic retinopathy from stereoscopic color fundus photographs - An extension of the modified Airlie House Classification Report Number 10. Ophthalmology 98:786-806, 1991
29. Consensus Panel: Report and recommendations of the San Antonio Conference on Diabetic Neuropathy. Ann Neurol 24:99-106, 1988
30. Marcell PD, Stabler SP, Podell ER, et al: Quantitation of methylmalonic acid and other dicarboxylic acids in normal serum and urine using capillary gas chromatography-mass spectrometry. Anal Biochem 150.58-66, 1985
31. Stabler SP, Marcell PD, Podell ER, et al: Quantitation of total homocysteine, total cysteine, and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry. Anal Biochem 162:185-196, 1987
32. Stabler SP, Lindenbaum J, Savage DG, et al: Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency. Blood 81:3404-3413, 1993
33. Allen RH, Stabler SP, Savage DG. et al: Elevation of 2-methyl-citric acid I and II levels in serum, urine, and cerebrospinal fluid of patients with cobalamin deficiency. Metabolism 42:978-988, 1993
34. Rasmussen K, Vyberg B, Pedersen KO, et al: Methylmalonic acid in renal insufficiency: Evidence of accumulation and implications for diagnosis of cobalamin deficiency. Clin Chem 36.1523-1524, 1990 (letter)
35. Hofmann, MA, Kohl B, Zumbach MS, et al: Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care 20 1880-1886, 1997
36. Chico A, Perez A, Cordoba A, et al: Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: A new link between diabetic nephropathy and cardiovascular disease? Diabetologia 41:684-693, 1998
37. Hoogeveen EK, Kostense PJ, Jager A, et al: Serum homocysteine level and protein intake are related to risk of microalbuminuria: The Hoorn Study. Kidney Int 54:203-209, 1998
38. Cameron NE, Cotter MA: The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab Rev 10:189-224, 1994
39. van Guldener C, Donker AJM, Jakobs C, et al: No net renal extraction of homocysteine in fasting humans. Kidney Int 54:166-169, 1998
40. Alfthan G, Pekkanen J, Jauhiainen M, et al: Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in prospective Finnish population-based study. Atherosclerosis 106:9-19, 1994
41. Verhoef P, Hennekens CH, Malinow MR, et al: A prospective study of plasma homocysteine and risk of angina pectoris: Results from a prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 25:1924-1930, 1994
42. Verhoef P, Stampfer MJ: Prospective studies of homocysteine and cardiovascular disease. Nutr Rev 53:283-287, 1995
43. Folsom AR, Nieto FJ, McGovern PG, et al: Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins. The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 98:204-210, 1998